Loading clinical trials...
Loading clinical trials...
Axillary lymph node dissection has long been regarded as standard if treatment of the axilla is indicated for patients with a positive sentinel node. Although axillary lymph node dissection provides e...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ruijin Hospital
NCT07188246 · Breast Cancer, Breast Cancer Stage II, and more
NCT06781281 · Breast Cancer Invasive
NCT06790264 · Breast Cancer Invasive, Node Positive Breast Cancer
NCT05939310 · Breast Cancer, Breast Cancer Invasive
NCT06234488 · Breast Cancer, Breast Neoplasms, and more
Ruijin hospital, Shanghai jiaotong university school of medicine
Shanghai, China
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions